治疗协调聚合物:通过金属-连接体相互作用量身定制药物释放
Jennifer N Murphy1,2, Joy-Lynn Kobti1, Michelle Dao1
1Department of Chemistry and Biochemistry, University of Windsor 401 Sunset Avenue Windsor ON N9B 3P4 Canada nick.vukotic@uwindsor.ca.
Chemical science
|May 17, 2024
概括
治疗协调聚合物 (TCP) 提供可调节的,持续的药物释放. 这些无孔材料利用组件降解来控制零阶动力学,非常适合扩展应用.
科学领域:
- 材料科学 材料科学 材料科学
- 药物运输 药物运输 药物运输
- 聚合物化学 聚合物化学
背景情况:
- 开发可调节的材料,以持续释放药物,面临重大挑战.
- 现有的药物释放系统通常依赖于基于扩散的机制.
- 从无孔协调聚合物中降解控制的释放仍然在很大程度上未被探索.
研究的目的:
- 引入治疗协调聚合物 (TCP),用于可调节的,持续的药物释放.
- 为了研究TCP的零顺序药物释放动力学.
- 为了探索TCP的刺激反应性药物释放.
主要方法:
- 使用生物相容组件合成的无孔协调聚合物:金属中心 (Mg,Mn,Zn,Cu),二烯酸作为阳离子药物,以及基二-胺醇结合剂.
- 描述了药物释放动力学和药物负载的重量%.
- 研究了对刺激有反应的药物释放行为.
主要成果:
- TCPs展示了可调节的零顺序药物释放动力学.
- 药物释放率跨越了三个数量级.
- 实现了高的药物负载 (重量%>62%).
- 观察到对刺激有反应的药物释放.
结论:
- TCP为控制,持续的药物输送提供了一个新的平台.
- 降解控制释放机制提供可调节的零顺序动力学.
- 由于其特性,TCP非常适合用于延长药物释放的应用.
相关概念视频
Metal-Ligand Bonds
20.7K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
20.7K
Complexation Equilibria: The Chelate Effect
505
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
505
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Drug-Receptor Bonds
2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.8K
EDTA: Chemistry and Properties
1.9K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
1.9K
Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K


